Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001064 | 54.0481 | 0.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 56.0631 | 21.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 59.0384 | 0.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 69.0581 | 0.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 71.0742 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 73.0534 | 1.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 83.0379 | 1.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 84.0218 | 1.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 85.0898 | 1.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 85.9863 | 0.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 86.0365 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 89.0482 | 0.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 92.0397 | 5.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 94.0420 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 99.0688 | 0.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 100.0015 | 0.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 101.0480 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 102.0320 | 1.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 102.0473 | 2.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 103.0458 | 1.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 103.1001 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 105.0428 | 0.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 106.0420 | 2.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 113.0836 | 4.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | CREATININE-(GUANIDINO-13C) [ISTD] (CAS# ); (2M+H)+ | 114.0612 | 0.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | CREATININE-(GUANIDINO-13C) [ISTD] (CAS# ); (M+NA)+ | 114.0629 | 0.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 115.0637 | 0.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 117.0794 | 0.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 117.1145 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 118.0288 | 3.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 118.0572 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 119.0737 | 2.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 120.0570 | 1.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 122.0484 | 1.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 124.0631 | 1.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 125.0150 | 0.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 126.0319 | 1.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 127.0633 | 5.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 127.0986 | 7.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 128.0114 | 0.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 129.0428 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 129.1517 | 4.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 130.0683 | 1.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 131.0697 | 0.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 131.0947 | 1.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 132.0264 | 0.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 133.0377 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 133.0516 | 1.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 133.0976 | 1.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 134.0944 | 4.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 135.0547 | 3.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 135.0556 | 4.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 135.0632 | 4.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 135.0685 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 136.0408 | 0.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 137.0480 | 5.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 137.9955 | 1.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 138.0437 | 1.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M+H)+ | 138.0454 | 5.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 138.0455 | 5.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 140.0584 | 0.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 141.0251 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 141.9402 | 0.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 142.0736 | 1.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 143.0580 | 1.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 143.0584 | 4.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 143.0935 | 0.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 144.0427 | 0.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 145.0743 | 1.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 145.1103 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 145.1568 | 0.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 146.0066 | 0.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 146.0510 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 147.0537 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 147.0555 | 3.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 148.0159 | 20.9 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 148.0526 | 2.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 149.0513 | 0.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 150.0891 | 2.27 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 150.1044 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 152.0331 | 1.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 153.0439 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 153.0479 | 0.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 154.0627 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 155.0693 | 1.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 155.0946 | 0.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 155.9557 | 0.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 156.0037 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 156.0772 | 3.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 156.0773 | 3.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 157.0852 | 1.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 157.1101 | 0.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 157.1463 | 15.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 157.9139 | 0.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 158.0585 | 1.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 158.0840 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 159.0356 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 159.0682 | 1.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 159.0892 | 4.05 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 159.1260 | 0.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 160.0581 | 6.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 160.0782 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 161.0149 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 161.0516 | 1.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 161.0696 | 0.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 161.1051 | 0.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 162.0363 | 4.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 162.0503 | 1.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 163.0319 | 1.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 163.0665 | 2.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 164.0475 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 164.1201 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 165.0654 | 0.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 165.0789 | 2.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 166.0259 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 166.9965 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 167.0510 | 5.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 167.0585 | 0.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 168.0032 | 0.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 168.1127 | 8.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 169.0355 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 169.0365 | 0.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 169.0739 | 1.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 169.0840 | 1.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 170.0508 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 170.0916 | 6.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 170.1409 | 10.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 171.1368 | 1.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 171.1611 | 17.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 171.9787 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 172.0733 | 2.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 172.0837 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 173.0689 | 5.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 175.0488 | 0.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 175.0633 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 176.0432 | 0.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 177.0790 | 0.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 178.0416 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 178.0629 | 3.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 178.1102 | 1.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 179.0584 | 5.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | D-MANNOSAMINE (CAS# 14307-02-9); (M+H)+[-H2O] | 179.0803 | 0.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 179.0941 | 4.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 181.0741 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 183.0662 | 0.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 184.0352 | 3.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 184.1075 | 10.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 185.1020 | 0.89 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 185.1281 | 1.03 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 186.0506 | 2.11 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 186.0890 | 4.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 187.1201 | 7.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 187.1672 | 0.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 188.0610 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 188.0814 | 0.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 189.0638 | 1.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | BOC-ALA-OH (CAS# 15761-38-3); (M+NA)+ | 189.1019 | 9.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 189.1361 | 2.31 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 191.0577 | 2.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 191.0617 | 4.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 192.1141 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 193.0175 | 6.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 193.0376 | 1.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 193.0405 | 1.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 193.0741 | 5.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 195.0663 | 0.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 195.0758 | 1.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 195.0866 | 5.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 195.0890 | 3.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 196.1199 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 197.0800 | 1.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 197.0816 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 197.9327 | 0.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 198.0511 | 6.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 199.1930 | 18.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 199.9659 | 0.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 200.0085 | 0.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 200.0671 | 2.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 200.1026 | 5.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 201.0404 | 4.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 201.0776 | 6.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 201.0998 | 3.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 201.1013 | 3.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 201.1728 | 1.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 202.0454 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 202.0589 | 11.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 202.0960 | 1.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 202.1305 | 6.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 202.1416 | 0.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 203.1160 | 0.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 204.0409 | 3.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 204.0739 | 1.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 204.0778 | 0.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 204.0781 | 20.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 204.0898 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 205.0479 | 0.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 205.0923 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | L-TRYPTOPHAN-15N2 [ISTD] (CAS# ); (M+H)+ | 206.0840 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 206.0841 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 207.0875 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 207.0933 | 2.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 208.0841 | 2.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 208.1068 | 10.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 209.1026 | 7.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 209.1764 | 16.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 209.1889 | 1.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 210.0879 | 10.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 210.0980 | 2.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 210.1256 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 211.0355 | 0.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 211.0813 | 5.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 211.1102 | 6.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 212.1158 | 1.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 212.1380 | 14.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 213.1277 | 14.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 213.9050 | 0.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 213.9830 | 0.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.0057 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.0094 | 1.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.0166 | 1.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.0945 | 2.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.1173 | 7.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 214.1307 | 1.27 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 215.0541 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 215.0820 | 3.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 215.1507 | 12.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 215.1875 | 14.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 216.0974 | 3.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 216.1110 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 217.1315 | 1.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 217.1782 | 0.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 217.9534 | 1.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 218.0109 | 3.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 218.0193 | 0.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 218.0902 | 0.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 218.1057 | 6.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 219.0742 | 1.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 219.1105 | 3.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 219.1121 | 3.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 220.0518 | 2.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 220.0837 | 1.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 220.1776 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 221.0219 | 0.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 221.1892 | 1.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 221.9973 | 5.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 222.0816 | 1.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 222.1218 | 10.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 222.9661 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 224.0779 | 1.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 224.1064 | 14.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 224.1872 | 16.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 226.0954 | 1.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 226.1296 | 1.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 227.0900 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 227.1875 | 16.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 228.1104 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 228.1335 | 10.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 228.9690 | 1.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.0118 | 4.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.1672 | 14.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.1783 | 1.39 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.2402 | 17.31 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.9825 | 1.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 229.9929 | 1.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 230.0769 | 3.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 230.0902 | 0.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 230.1127 | 5.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 231.1470 | 2.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 232.0519 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 232.0713 | 10.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 232.1059 | 1.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 232.1076 | 13.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 232.1151 | 1.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 234.1234 | 15.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 235.1413 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 235.1545 | 22.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | IBUPROFEN CARBOXYLIC ACID (CAS# 15935-54-3); (M+H)+[-H2O] | 236.1038 | 12.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 237.1330 | 12.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 237.1687 | 14.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 237.2075 | 19.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 238.0821 | 7.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 238.1414 | 4.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 238.1543 | 18.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 239.0435 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 239.0948 | 2.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 239.1018 | 1.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 240.0620 | 8.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 240.1329 | 14.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 240.1467 | 1.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 240.1694 | 18.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 242.0433 | 1.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 242.0438 | 1.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 242.1494 | 0.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 242.1769 | 0.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 243.1468 | 4.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 243.1827 | 15.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 244.0522 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 244.0892 | 6.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 244.1059 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 245.1627 | 4.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 246.0507 | 0.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 246.1217 | 2.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 246.1223 | 16.11 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 246.1324 | 0.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 247.0260 | 1.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 247.0678 | 1.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 247.1417 | 1.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.0727 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.0999 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.1039 | 17.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.1395 | 17.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.1479 | 0.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.1749 | 19.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 248.1751 | 21.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 249.1702 | 22.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 250.0635 | 1.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 250.0719 | 2.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 251.1024 | 2.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 251.1492 | 14.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 252.1386 | 18.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 252.2054 | 22.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 253.0955 | 5.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 253.1642 | 12.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 254.0897 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 254.0903 | 0.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 256.0562 | 6.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 256.1437 | 21.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 257.0530 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 257.0622 | 3.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 257.1026 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 257.1031 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 258.1436 | 8.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 259.1150 | 1.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 259.1776 | 7.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 260.1026 | 14.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 260.1239 | 4.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 260.1353 | 3.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 260.1374 | 4.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 261.1571 | 2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 262.0779 | 0.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 262.0802 | 0.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 263.0069 | 0.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 263.0109 | 5.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 264.0838 | 1.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 264.1044 | 0.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 265.1648 | 22.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 265.1650 | 22.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 265.2381 | 21.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 266.2202 | 22.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 267.1795 | 14.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 267.9412 | 0.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 268.2003 | 21.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 269.9389 | 0.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 270.0676 | 2.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 271.9367 | 0.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 272.1031 | 18.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 272.1738 | 21.01 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 273.0305 | 3.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 273.1317 | 2.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 273.1934 | 9.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 273.2046 | 1.05 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 273.2663 | 17.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 274.1030 | 4.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 275.0642 | 1.34 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 275.1727 | 2.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 276.0985 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 276.2068 | 22.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 277.0593 | 1.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 277.1088 | 0.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 277.2358 | 22.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 278.1519 | 20.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 279.0852 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 280.0994 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 280.1714 | 20.06 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 281.1119 | 1.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 281.1963 | 16.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 282.0632 | 0.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 282.0948 | 2.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 282.1257 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 282.1671 | 6.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 282.2168 | 21.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 283.0988 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 284.1398 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 285.0486 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 286.0806 | 1.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 286.1906 | 19.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 287.2821 | 16.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 288.0411 | 1.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 288.1469 | 20.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 288.1473 | 20.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 289.1271 | 1.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 289.2612 | 17.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 290.0604 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 291.0958 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 292.2010 | 20.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 293.1476 | 1.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 293.1956 | 18.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 294.0779 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 294.1203 | 5.06 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 294.1869 | 22.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 295.0594 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 295.2093 | 18.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 295.9357 | 0.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 296.1457 | 5.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 296.1977 | 21.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 296.2345 | 22.27 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 297.0898 | 4.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 297.1046 | 2.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 297.2664 | 19.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 298.1542 | 19.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 299.2805 | 20.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 300.1094 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 300.1123 | 5.39 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 300.1339 | 20.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 301.1889 | 3.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 301.2944 | 20.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 303.0249 | 0.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 303.1050 | 1.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 303.1428 | 2.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 303.1533 | 0.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 303.2906 | 18.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 304.0255 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 304.1621 | 1.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 305.1224 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 305.2478 | 17.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 306.1083 | 7.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 307.0840 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 308.1196 | 10.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 308.1986 | 21.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 308.2329 | 22.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 309.2267 | 20.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 310.2138 | 21.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 310.2471 | 22.55 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 310.9750 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 311.3535 | 21.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 312.0060 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 312.2273 | 22.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 313.0854 | 1.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 314.0567 | 1.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 314.1349 | 0.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 314.1503 | 20.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 315.2040 | 5.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 315.3130 | 19.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 316.1734 | 0.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 316.2009 | 21.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 316.2363 | 23.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 317.1586 | 3.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 317.2914 | 16.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 318.0421 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 318.0622 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 318.1290 | 5.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 319.0363 | 3.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 319.0498 | 1.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 319.0840 | 0.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 319.0840 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 320.0574 | 1.06 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 320.1238 | 9.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 321.0699 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 321.0905 | 1.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 321.0952 | 1.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 321.0953 | 1.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | THYMIDINE 5'-MONOPHOSPHATE (CAS# 365-07-1); (2M+NA)+ | 322.0542 | 1.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | THYMIDINE 5'-MONOPHOSPHATE (CAS# 365-07-1); (M+NA)+ | 322.0584 | 1.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 322.0891 | 8.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 322.1193 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 322.2198 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 323.0498 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 323.2113 | 20.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 324.0409 | 0.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | N-ACETYL-L-CYSTEINE (CAS# 616-91-1); (M+H)+ | 324.0424 | 3.39 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 324.2271 | 22.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 324.2609 | 22.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 325.0527 | 1.31 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 325.1379 | 2.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 325.3696 | 21.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 326.1935 | 7.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 326.2232 | 22.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 326.2388 | 21.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 326.9496 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 327.1059 | 0.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 328.1314 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 329.0497 | 0.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 329.0546 | 1.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 329.0662 | 0.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 329.1246 | 2.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 330.1807 | 19.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 330.2164 | 22.01 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 331.0865 | 0.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 331.1374 | 2.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 331.3234 | 20.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 334.0867 | 0.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 334.0980 | 15.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 334.0988 | 7.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 334.0993 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 334.1181 | 20.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 335.9788 | 1.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 336.0971 | 18.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 336.1489 | 21.9 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 336.1559 | 5.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 336.2636 | 22.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 337.0447 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 337.0945 | 0.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 337.1401 | 10.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 337.3345 | 23.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 338.0646 | 0.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 338.1220 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 338.2425 | 21.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 338.2464 | 22.39 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 338.2783 | 22.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 340.2372 | 23.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 340.2568 | 22.31 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 342.1471 | 8.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 342.1814 | 22.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 342.2524 | 23.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 343.0519 | 1.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 343.0836 | 1.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 343.1387 | 1.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 343.3440 | 20.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 345.0397 | 0.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 345.1138 | 1.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 345.1524 | 3.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 346.0176 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 347.0628 | 0.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 347.2797 | 22.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 347.9815 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 348.0529 | 19.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 348.2630 | 22.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 348.2632 | 22.95 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 348.2661 | 22.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 349.0946 | 2.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 350.0611 | 0.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 350.1691 | 1.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 350.2443 | 22.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 350.2448 | 22.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 351.1105 | 1.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 352.1006 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 352.1080 | 10.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 352.1097 | 10.05 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 352.2591 | 22.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 354.0569 | 11.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 354.0673 | 1.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 354.1470 | 0.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 356.1682 | 1.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 356.2410 | 0.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 357.3002 | 22.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 357.3561 | 21.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 358.0104 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 358.2329 | 19.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 358.3084 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 359.1322 | 2.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 359.3146 | 23.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 359.3543 | 21.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.0552 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.1792 | 0.9 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.1940 | 13.42 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.2000 | 1.22 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.2257 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 360.2646 | 22.01 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 361.0785 | 1.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 361.2950 | 22.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 362.1048 | 20.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 362.1550 | 6.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 362.1802 | 0.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 363.0576 | 0.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 363.1100 | 1.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 363.1683 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 364.1303 | 20.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 364.2419 | 23.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 364.2640 | 22.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 364.2676 | 22.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 364.2687 | 19.03 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 365.0892 | 2.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 365.0894 | 3.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 365.1255 | 1.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.1257 | 12.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.1312 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.1425 | 2.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.2554 | 23.22 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.2740 | 22.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 366.3066 | 23.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 367.4164 | 22.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.1238 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.1936 | 22.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.2251 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.2422 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.2662 | 23.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.2829 | 22.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 368.3440 | 24.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 370.1377 | 1.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 370.1399 | 8.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 370.1766 | 21.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 370.1854 | 2.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 370.2197 | 7.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 371.0749 | 2.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 371.2307 | 22.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 372.0498 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 372.1317 | 5.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 372.1913 | 21.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 372.2007 | 2.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 373.1234 | 1.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 374.1073 | 1.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 374.1906 | 1.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 374.1906 | 1.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 374.2428 | 22.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 374.9893 | 1.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 375.2958 | 23.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 375.3079 | 22.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 375.3122 | 22.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 376.0385 | 15.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 376.1388 | 7.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 376.2611 | 22.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 377.1238 | 2.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 378.0630 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 378.2044 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 378.2749 | 22.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 379.1050 | 1.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 379.1410 | 2.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 380.0726 | 0.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 380.1262 | 13.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 380.2905 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 381.1638 | 1.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 382.2113 | 17.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 383.1077 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 383.1865 | 22.29 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 383.9188 | 0.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.1215 | 1.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.1634 | 1.96 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.1981 | 21.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.2007 | 21.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.2822 | 22.34 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 384.2835 | 22.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 385.9167 | 0.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 386.1732 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 386.1736 | 17.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 386.2073 | 21.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 387.1684 | 1.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 387.3428 | 23.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 388.1752 | 0.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 388.2046 | 1.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 390.1005 | 21.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 390.1833 | 0.9 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 390.2772 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 392.1798 | 2.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 392.2199 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 392.2860 | 23.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 392.2998 | 21.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 393.0847 | 1.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 394.2721 | 21.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 394.3021 | 23.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 396.1555 | 1.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 396.2367 | 23.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 396.2643 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 396.2811 | 21.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.0108 | 0.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | S-ADENOSYLMETHIONINE (CAS# 29908-03-0); (M+H)+ | 398.1371 | 0.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001064 | 398.1371 | 0.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.2115 | 21.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.2141 | 22.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.2461 | 21.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.2964 | 22.55 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 398.2987 | 23.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 400.1120 | 1.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 400.1865 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 400.2070 | 2.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 400.2580 | 22.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 400.2586 | 22.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 401.3482 | 21.23 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 402.0763 | 12.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 402.0793 | 5.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 402.2751 | 22.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 402.2762 | 22.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 403.1993 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 404.0026 | 0.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 404.1354 | 1.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 404.1903 | 0.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 404.2011 | 1.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 404.2538 | 21.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 405.3173 | 22.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 406.3028 | 22.95 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 407.0986 | 2.59 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 407.0992 | 2.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 407.0995 | 2.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 407.3014 | 22.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.0795 | 1.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.1553 | 17.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.1554 | 17.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.1556 | 15.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.1703 | 19.03 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.2482 | 17.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 408.3213 | 23.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 409.1031 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 409.1588 | 1.89 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 410.1711 | 3.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 410.2984 | 22.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 411.1315 | 1.03 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 412.1341 | 5.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 412.1886 | 20.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 412.2592 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 412.3106 | 22.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 414.2021 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 414.2048 | 18.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 414.2280 | 22.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 415.2174 | 1.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 415.2207 | 6.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 416.1522 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 416.2014 | 1.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 417.2150 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 418.0511 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 418.2679 | 22.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 419.1579 | 1.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 419.1898 | 1.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 420.2255 | 21.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 420.2487 | 22.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 420.3267 | 22.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 421.1641 | 3.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 422.1123 | 1.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 422.3053 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 422.3168 | 23.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 422.3219 | 23.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 423.0937 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 423.2722 | 22.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.1296 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.2075 | 21.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.2581 | 22.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.2610 | 22.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.3127 | 22.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.3293 | 23.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 424.3311 | 23.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 425.0799 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.0810 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.2420 | 22.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.2475 | 22.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.2493 | 22.42 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.2783 | 22.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.3306 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 426.3455 | 23.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 427.0303 | 0.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 427.1690 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.2221 | 21.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.2269 | 22.27 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.2569 | 22.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.2645 | 22.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.2867 | 22.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 428.3000 | 22.34 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 429.2224 | 2.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 429.3808 | 21.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 430.0940 | 8.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 430.1682 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 430.2327 | 21.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 431.2289 | 18.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 431.2305 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 432.1968 | 1.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 432.3012 | 23.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 434.2012 | 1.67 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 434.2627 | 1.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 434.3340 | 23.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 434.3372 | 23.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 435.1406 | 1.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 435.1841 | 1.48 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 435.3342 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1258 | 1.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1266 | 1.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1306 | 1.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1868 | 19.31 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1871 | 18.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1874 | 17.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1887 | 19.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.1899 | 20.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.2285 | 8.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 436.3512 | 23.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 438.2523 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 438.2938 | 21.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 439.2206 | 22.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.1686 | 0.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.2204 | 21.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.2211 | 21.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.2914 | 23.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.3250 | 4.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.3281 | 23.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 440.3366 | 23.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 441.0458 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 441.1825 | 0.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 442.2338 | 21.9 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 442.2612 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 442.3211 | 22.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 443.0225 | 0.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 444.2487 | 22.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 444.2488 | 21.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 444.2520 | 22.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 444.3235 | 19.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 445.2421 | 22.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 445.2422 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 445.2456 | 18.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 446.0496 | 12.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.1220 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.2149 | 2.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.2155 | 1.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.2779 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.2780 | 22.91 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 448.2797 | 21.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 449.3496 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 450.1117 | 1.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 450.3329 | 23.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 451.2715 | 21.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 451.2901 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 452.1616 | 1.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 452.1659 | 18.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 452.1668 | 18.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 452.1830 | 19.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 452.3240 | 23.88 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 453.0900 | 0.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 453.1598 | 1.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 453.1747 | 2.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 453.2864 | 22.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 453.2872 | 22.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 454.0745 | 1.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 454.3064 | 23.53 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 454.3251 | 22.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 455.1186 | 11.61 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 455.2015 | 2.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 456.1423 | 1.23 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 456.2493 | 22.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 456.2581 | 7.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 456.3409 | 23.83 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 457.2236 | 2.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 457.3319 | 22.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 458.0763 | 1.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 458.1986 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 458.1991 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 458.2284 | 21.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 458.2305 | 21.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 459.2327 | 2.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 459.2610 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 459.2612 | 18.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 459.2749 | 22.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 460.2078 | 3.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 462.2957 | 22.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 462.3328 | 19.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 463.0739 | 2.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 463.3642 | 23.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 464.2152 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 464.2162 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 464.9901 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 465.3060 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 467.3011 | 21.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 468.1245 | 1.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 468.3562 | 23.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 469.1363 | 1.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 469.2507 | 1.78 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 470.1260 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 470.2732 | 8.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 470.3567 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 471.4236 | 23.8 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 472.1120 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 472.3355 | 22.36 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 473.2480 | 2.68 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 473.2527 | 21.7 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 473.2731 | 18.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 474.2330 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 476.1433 | 16.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 476.1682 | 3.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 476.1724 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 477.0239 | 1.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 478.3273 | 18.95 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 479.3039 | 22.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 480.1269 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 480.2484 | 23.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 480.2546 | 9.49 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 480.2767 | 23.25 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 480.3452 | 19.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 481.3528 | 22.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 482.1848 | 3.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 483.1094 | 1.32 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 483.2696 | 0.84 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 484.1062 | 22.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 484.1389 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 484.2998 | 0.75 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 484.3328 | 23.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 484.3521 | 23.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 485.1637 | 1.41 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 486.3510 | 22.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 487.2316 | 2.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 487.2927 | 18.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 487.2992 | 22.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 489.1261 | 1.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 489.2156 | 1.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 489.2814 | 21.55 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 489.2832 | 21.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 490.1559 | 21.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 492.1404 | 3.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 492.3073 | 21.74 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 493.3163 | 21.73 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 495.2381 | 21.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 495.3327 | 22.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 496.1928 | 21.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 496.3881 | 24.54 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 497.2496 | 22.14 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 498.1220 | 22.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 498.1967 | 2.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 499.2712 | 21.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 500.3113 | 19.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 500.3660 | 22.76 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 501.2874 | 21.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 501.3186 | 22.46 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 502.1440 | 1.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 502.3263 | 19.04 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 502.3275 | 19.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 502.3671 | 22.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 503.2986 | 21.79 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 503.3005 | 22.28 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 503.3007 | 22.01 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 503.3073 | 22.65 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 503.3350 | 22.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 504.1713 | 21.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 505.3202 | 22.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 506.3189 | 22.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 507.2070 | 22.81 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 509.1399 | 1.43 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 510.2499 | 22.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 510.3476 | 22.98 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 512.1366 | 23.11 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 512.3306 | 22.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 513.2799 | 21.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 514.3473 | 22.44 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 514.3840 | 22.93 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 515.2988 | 21.77 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 515.3099 | 4.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 516.2857 | 19.64 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 517.2524 | 21.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 518.3009 | 19.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 518.3015 | 19.52 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 518.3221 | 17.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 519.3345 | 21.94 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 520.3275 | 4.26 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 520.4461 | 25.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 521.3480 | 22.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 521.3484 | 22.27 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 521.5892 | 22.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 522.2109 | 22.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 523.2676 | 22.24 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 523.3013 | 22.45 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 523.3637 | 22.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 524.2802 | 10.13 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 525.2847 | 22 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 525.2850 | 22.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 525.3201 | 22.71 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 526.1183 | 1.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 526.1830 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 527.3014 | 22.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 527.3033 | 22.15 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 527.3037 | 22.38 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 527.3286 | 22.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 529.3134 | 22.01 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 529.3181 | 22.37 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 529.3590 | 22.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 531.2656 | 21.69 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 531.3297 | 22.4 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 531.3307 | 22.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 531.3659 | 22.85 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 531.4623 | 23.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 533.2839 | 22.1 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 533.2871 | 22.12 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 534.2962 | 18.92 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 534.2978 | 17.87 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 534.3162 | 17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 534.3165 | 16.35 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 536.1873 | 0.6 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 536.3325 | 21.82 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 537.1202 | 1.33 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 537.5118 | 22.57 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 538.3217 | 4.42 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 539.2353 | 21.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 541.0602 | 1.02 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 541.3164 | 21.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 541.3165 | 22.08 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 543.2408 | 21.63 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 543.3324 | 21.97 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 545.2498 | 21.99 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 545.3458 | 22.66 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 545.3480 | 22.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 545.4770 | 24.09 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 547.2674 | 22.07 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 548.4772 | 26.18 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 549.6208 | 22.72 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 550.3432 | 22.2 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 551.2993 | 22.47 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 552.1262 | 21.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 552.1606 | 0.62 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 552.3831 | 23.86 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 552.4507 | 26.5 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 553.3078 | 22.05 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 553.3154 | 22.58 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 554.1191 | 1.16 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 554.1837 | 13.19 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 555.3037 | 22.21 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 557.2694 | 21.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 557.2704 | 21.3 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 557.3414 | 22.51 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 557.3467 | 22.56 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001064 | 557.3827 | 23.17 | Minutes | ST000689 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |